Paxman Q2’24: A tad better than expected - Redeye

Redeye saw a sales development roughly in line with what was expected. Costs were a bit lower than expected in the quarter, where operating costs improved. Paxman is still showing impressive growth, with a 24% increase in the quarter. Cost control compensates for slightly lower sales than expected. The quarters can be volatile. However, with a solid performance, our confidence in the case remains, and there is a long runway of potential growth ahead.

Länk till analysen i sin helhet: https://www.redeye.se/research/1031987/paxman-q224-a-tad-better-than-expected?utm_source=finwire&utm_medium=RSS